1,25 (OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1α and receptor activator of NF-κB ligand production in osteoblasts

Journal of Immunology

Volumn 169, Issue 5, 2002, Pages 2374-2380

  Lee, Sun Kyeong ^a   Kalinowski, Judy ^a   Jastrzebski, Sandra ^a   Lorenzo, Joseph A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALVARIA; CELL DIFFERENTIATION; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; GENE EXPRESSION; KNOCKOUT MOUSE; MALE; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0036721615     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.5.2374     Document Type: Article

References (59)

1. The biological properties of interleukin-1
2. Local regulators of bone: IL-1, TNF, and lymphotoxin, interferon γ, IL-8, IL-10, IL-4, the LIF/IL-6 family and additional cytokines
3. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period
4. Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy
5. Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine
6. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1β gene
7. Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women
8. Interleukin-1 and interleukin-1 antagonism
9. The interleukin-1 system: Receptors, ligands and signals
10. Estrogen decreases the steady state levels of the IL-1 signaling receptor (type I) while increasing those of the IL-1 decoy receptor (type II) mRNAs in human osteoclast-like cells
11. The interleukin-1 receptor accessory protein (IL-IRAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)
12. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
13. Osteoblastic cells are involved in osteoclast formation
14. RANKing the importance of measles virus in Paget's disease
15. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
16. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1
17. Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor
18. Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures
19. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: Correlation with osteoclast-like cell formation
20. 3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells
21. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells
22. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: A specific marker of the differentiated osteoclast that is regulated by calcitonin
23. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures
24. Preparation and characterization of a mouse osteoclast-like multinucleated cell population
25. Prostaglandins promote osteoclast-like cell formation by a mechanism involving cyclic adenosine 3′,5′-monophosphate in mouse bone marrow cell cultures
26. Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures
27. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
28. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
29. Comparison of the three actin-coding sequences in the mouse: Evolutionary relationships between the actin genes of warm-blooded vertebrates
30. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli
31. Two interleukin 1 genes in the mouse: Cloning and expression of the cDNA for murine interleukin 1-β
32. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte
33. The role of interleukin-1 in disease
34. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro
35. 2 stimulates osteoclast formation via endogenous IL-1β expressed through protein kinase A
36. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast like cells in vitro
37. 3 induces maturation of the human monocyte cell line U-937 and in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor
38. 3
39. 3
40. Lipopolysaccharide supports survival and fusion of preosteoclast independent of TNF-α, IL-1 and RANKL
41. 3 metabolites on the production of interleukin 1, 2 and 3
42. 3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 production
43. Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation
44. Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation
45. 17β-oestradiol and 1α, 25-dihydroxycholecalciferol modulate constitutive and bone matrix-induced interleukin-1β (IL-1β) production by peripheral blood mononuclear cells isolated from postmenopausal women
46. 3, 17β-estradiol, and testosterone is age dependent in primary cultures of mouse-derived osteoblasts in vitro
47. 3 inhibits cytokine production by human blood monocytes at the post-transcriptional level
48. 3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1β production
49. 3 as a natural regulator of human immune functions
50. 3 on cytokine production by human corneal epithelial cells
51. 3 or parathyroid hormone
52. Interleukin-1α activates all NF-κB-like factor in osteoclast-like cells
53. 3 decreases DNA binding of nuclear factor-κB in human fibroblasts
54. 3
55. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells
56. Osteoblasts mediate interieukin1 stimulation of bone resorption by rat osteoclasts
57. Production of both interleukin-1α and β by newborn mouse calvaria cultures
58. Cytokines, estrogen, and postmenopausal osteoporosis - The second decade
59. 3 by hematopoietic cells